APF
VRTX icon

Alaska Permanent Fund’s Vertex Pharmaceuticals VRTX Stock Holding History

Alaska Permanent Fund’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-26,346
Closed -$13.4M – 427
2025
Q1 		$13.4M Hold
26,346
– – 0.19% 56
2024
Q4 		$10.6M Hold
26,346
– – 0.16% 64
2024
Q3 		$12.3M Hold
26,346
– – 0.18% 58
2024
Q2 		$13.1M Sell
26,346
-501
-2% -$217K 0.19% 52
2024
Q1 		$11.2M Sell
26,847
-3,320
-11% -$1.4M 0.17% 62
2023
Q4 		$12.3M Buy
30,167
+4,497
+18% +$1.66M 0.2% 50
2023
Q3 		$8.93M Buy
25,670
+12,380
+93% +$4.33M 0.17% 74
2023
Q2 		$4.68M Buy
+13,290
New +$4.48M 0.09% 106
2022
Q4 		$158K Sell
549
-44
-7% -$13.4K ﹤0.01% 334
2022
Q3 		$171K Sell
593
-219
-27% -$63K ﹤0.01% 328
2022
Q2 		$229K Sell
812
-269
-25% -$72K ﹤0.01% 315
2022
Q1 		$282K Buy
1,081
+117
+12% +$27.8K ﹤0.01% 241
2021
Q4 		$235K Buy
+964
New +$187K ﹤0.01% 250

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Alaska Permanent Fund's VRTX Position: Q2 2025 in Review

Alaska Permanent Fund sold out of Vertex Pharmaceuticals (VRTX) in Q2 2025, closing a stake of 26,346 shares — an estimated $13.4M sold.

Alaska Permanent Fund first reported a position in VRTX in Q4 2021 and held it in 13 quarters. The position peaked at $13.4M in Q1 2025. 1,562 funds tracked by Wall St. Rank hold VRTX as of Q2 2025.

  • Alaska Permanent Fund reported no remaining Vertex Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Alaska Permanent Fund sold 26,346 Vertex Pharmaceuticals shares in Q2 2025, an estimated $13.4M.
  • Alaska Permanent Fund first reported a position in Vertex Pharmaceuticals in Q4 2021 and held it in 13 quarters.
  • Alaska Permanent Fund's Vertex Pharmaceuticals position peaked at $13.4M in Q1 2025.
  • 1,562 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2025.

Based on Alaska Permanent Fund's 13F filing for Q2 2025, filed 14 Aug 2025.